327) ers displayed little systematic under- or over-estimation in velocity relative to a |
328) ligand that can target sigma 2 receptors over-expressed in non-small cell lung canc |
329) ovides a testable account of compensatory over-recruitment in OAs. |
330) Yet, the neural mechanisms of over-recruitment in older adults (OAs) are |
331) siologically based extraction test (PBET) over 1 year. |
332) erapy, using resonance frequency analysis over 1 year. |
333) nance frequency analysis (Osstell Mentor) over 1 year. |
334) Attrition in the three groups over 12 months was low and non-differentia |
335) justment to multiple sclerosis caregiving over 12 months. |
336) effectiveness in reducing falls incidence over 12 months. |
337) ) strengthened the persistence of LTD for over 24 h. |
338) atient to rate current pain, average pain over 24 hours, over 1 week, or over 4 week |
339) ith etanercept therapy at all time points over 24 weeks (p<0.001) independent of |
340) The over 65 group had significantly greater va |
341) : aged 65 years or less (n = 14) and aged over 65 years (n = 16). |
342) ing outcomes; however, 1-3% of those aged over 65 years experience delayed wound hea |
343) t 180, 200, and 220 ℃ for 7 h daily over four consecutive days. |
344) sessions of LPT were carried out per week over four consecutive weeks, in the total |
345) ed 30 novel words for manipulable objects over four days. |
346) To assess the effect of resazurin over longer incubation times, MCF7 (HTB-22 |
347) conditions that prevent dedifferentiation over longer periods. |
348) clear whether reappraisal effects persist over longer time periods. |
349) t systems and an increase in market share over other connections. |
350) Rendering efficiency is further improved over other marching isosurfacing algorithm |
351) illness, pain and medical diagnoses) over other types of stressors, and patient |
352) 2 hours significantly favored telcagepant over placebo (odds ratio = 2.48, 95% confi |
353) 2 hours significantly favored telcagepant over placebo (odds ratio = 2.70, 95% confi |
354) significant superiority of 5% topical RJ over placebo for the treatment of DFUs. |
355) rmed taking images at 10-second intervals over 2 minutes during manual lymphatic the |
356) ing of pressure ulcers and chronic wounds over 2 years. |
357) d here after three 10-minute compressions over 30 minutes in a patient taking aspiri |
358) ional Formulary has been in existence for over 30 years. |
359) average pain over 4 weeks) has a significant influence |
|